Symbolic illustration of the mortality gap, with a bridge connecting light and dark sides.

Bridging the Gap: Understanding Mortality in Bipolar Disorder and Schizophrenia

Avery Sinclair monogram
Avery Sinclair in Health & Wellness November 2026 • 4 min read.

"A deep dive into a UK-based study reveals critical insights into the mortality gap affecting individuals with bipolar disorder and schizophrenia."


Mental health disorders, particularly bipolar disorder and schizophrenia, present significant challenges for those affected, as well as for healthcare systems and society at large. Beyond the daily struggles of managing symptoms, individuals with these conditions often face a stark reality: a significantly reduced life expectancy compared to the general population. This disparity, known as the mortality gap, is a critical area of concern that demands urgent attention and targeted interventions.

A study published in the British Journal of Psychiatry sheds light on this pressing issue. The research, a UK-based cohort study spanning from 2000 to 2014, delves into the mortality rates of individuals diagnosed with bipolar disorder and schizophrenia, offering valuable insights into the factors contributing to this increased risk of death. By examining a large sample over an extended period, the study provides a comprehensive overview of the challenges faced by this vulnerable population.

This article unpacks the key findings of the study, exploring the specific causes of mortality, the demographic trends observed, and the implications for healthcare practices and public health policies. By understanding the nuances of this mortality gap, we can work towards developing more effective strategies to support individuals with bipolar disorder and schizophrenia, ultimately improving their quality of life and extending their life expectancy.

AI Search Multiple angles on this topic

U.S. Bipolar Disorder Mortality Trends

A study of bipolar disorder-related mortality reported that the rate at which bipolar disorder was mentioned on death certificates increased throughout the study period. It also found that mortality associated with bipolar disorder increased with age. The study reported statistically significant increases in age-adjusted mortality rates when analyzed in groups.

What Factors Contribute to the Mortality Gap?

Symbolic illustration of the mortality gap, with a bridge connecting light and dark sides.

The UK-based cohort study from 2000-2014 revealed several key factors contributing to the mortality gap in individuals with bipolar disorder and schizophrenia. Understanding these factors is crucial for developing targeted interventions and improving healthcare outcomes.

One of the most significant findings was the increased risk of death from natural causes. Cardiovascular disease, respiratory illnesses, and diabetes were disproportionately prevalent among individuals with bipolar disorder and schizophrenia compared to the general population. This suggests that the chronic stress and lifestyle factors associated with these mental health conditions can significantly impact physical health.

  • Cardiovascular Disease: Individuals with bipolar disorder and schizophrenia often have higher rates of smoking, poor diet, and sedentary lifestyles, all of which contribute to heart problems.
  • Respiratory Illnesses: Smoking and other environmental factors can exacerbate respiratory issues, leading to chronic conditions like COPD.
  • Diabetes: Antipsychotic medications, commonly prescribed for these conditions, can increase the risk of metabolic syndrome and type 2 diabetes.
AI Search Multiple angles on this topic

What Drives the Mortality Gap?

A UK-based cohort study examined the mortality gap for people with bipolar disorder and schizophrenia from 2000 to 2014. The study says that a comprehensive understanding of how severe mental illness shortens life remains elusive. It describes a potential syndemic involving psychiatric and physical comorbidity, substance misuse, adverse social factors, and lifestyle behaviours.

A Limitation in Bipolar Mortality Estimates

A population-based cohort study of cause-specific excess mortality after a first bipolar disorder diagnosis cautions that excluding people with a history of schizoaffective disorder likely underestimated excess mortality in bipolar disorder. The authors say this underestimation is particularly likely for external causes. They note that persistent psychotic symptoms, including delusions and hallucinations, are known to be associated with markedly increased mortality.

Years of Potential Life Lost

A systematic review and meta-analysis reports that recent meta-analyses estimated 12.8 years of potential life lost (YPLL) in bipolar disorder and 14.5 years in schizophrenia. A separate bipolar disorder meta-analysis found a weighted average YPLL of 12.89 years, with a 95% confidence interval of 12.72–13.07 years. It reported that YPLL was greatest in Africa.

The study also highlighted the role of external causes, such as suicide and accidents, in the mortality gap. Suicide rates are significantly higher among individuals with bipolar disorder and schizophrenia, underscoring the need for improved mental health support and crisis intervention services. Accidents, which may be linked to impaired judgment or substance abuse, also contribute to this increased risk.

Taking Action: Bridging the Mortality Gap

Addressing the mortality gap in individuals with bipolar disorder and schizophrenia requires a multi-faceted approach involving healthcare providers, policymakers, and community organizations. By implementing targeted interventions and promoting holistic care, we can work towards improving the health and well-being of this vulnerable population. Prioritizing mental health is not just about treating symptoms; it's about ensuring that everyone has the opportunity to live a long and fulfilling life.

AI Search Multiple angles on this topic

Demographic Patterns in U.S. Mortality

A study using the CDC WONDER database examined bipolar disorder-related mortality from 1999 to 2023. It reported higher mortality rates among females than males, with variation by race and ethnicity. Mortality was highest among the Non-Hispanic White cohort.

The Mortality Disparity in Context

Both overview pages identify increased mortality among people with bipolar disorder and schizophrenia as a critical concern. One describes factors contributing to the disparity and potential solutions as central topics. The other highlights a UK study examining the mortality gap between these groups and the general population, as well as contributing factors and ways to improve outcomes.

Progress Without Closing the Gap

A UK-based study of people with bipolar disorder or schizophrenia suggests that overall mortality declined importantly after 2000. However, it also found that interventions intended to improve health outcomes for these groups had not reduced the mortality gap. Thus, improvement in overall mortality did not mean that the disparity had narrowed.

Life-expectancy estimates across mental health conditions

  • 14.66 years of potential life lostAcross mental disorders, a separate meta-analysis found a pooled 14.66 years of potential life lost relative to the general population.[1]
  • 15–20 years shorterIn Denmark, Finland and Sweden, severe mental disorders were associated with life expectancy approximately 15–20 years shorter than in the general population.[2]

Physical illness and early death are connected

The mortality picture is not limited to suicide: physical comorbidities are described as the most frequent causes of death, even though suicide has the highest relative risk. This distinction separates how likely a cause is relative to a comparison group from how often it accounts for deaths.[3]

Higher mortality from both medical conditions and external causes indicates that the disparity spans distinct kinds of death; the wide range reported for external causes also cautions against treating that risk as uniform.[2]

How estimates compare across settings and diagnoses

The cause-specific bipolar cohort excluded people with prior schizophrenia-spectrum diagnoses and ended follow-up for those later diagnosed in that spectrum. Its estimates therefore address a more restricted group than analyses that include such patients.[4]

What mortality estimates leave unresolved

  • How much do mortality estimates change when people with schizophrenia-spectrum diagnoses are included in bipolar cohorts, especially when the outcome is an external cause of death? The cohort restriction makes that comparison consequential, but does not quantify the excluded group’s contribution.[4]
  • What is the full mortality burden after discharge in the Canadian program? Its follow-up did not capture that period.[5]

Sources

  1. Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis (pmc.ncbi.nlm.nih.gov)
  2. Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden (pmc.ncbi.nlm.nih.gov)
  3. All-cause and cause-specific mortality among people with bipolar disorder: a large-scale systematic review and meta-analysis (pmc.ncbi.nlm.nih.gov)
  4. Cause-specific excess mortality after first diagnosis of bipolar disorder: population-based cohort study (pmc.ncbi.nlm.nih.gov)
  5. Mortality Rate and Causes of Death in a Canadian Tertiary Schizophrenia Program (journals.sagepub.com)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the 'mortality gap' in the context of bipolar disorder and schizophrenia?

The 'mortality gap' refers to the significant difference in life expectancy between individuals diagnosed with bipolar disorder and schizophrenia compared to the general population. This gap highlights the reduced lifespan experienced by those with these mental health conditions, pointing to unmet needs in healthcare and support systems. A UK-based cohort study spanning from 2000 to 2014, shows that those with bipolar disorder and schizophrenia have a higher risk of death. This study suggests that understanding the nuances of this mortality gap allows for the development of effective strategies to support individuals with bipolar disorder and schizophrenia, improving their quality of life and extending their life expectancy.

2

According to the UK study, what are the primary 'natural causes' contributing to the increased mortality risk in individuals with bipolar disorder and schizophrenia?

The UK study identifies cardiovascular disease, respiratory illnesses, and diabetes as significant 'natural causes' contributing to the increased mortality risk among individuals with bipolar disorder and schizophrenia. These conditions are often exacerbated by lifestyle factors, such as higher rates of smoking, poor diet, and sedentary behavior, as well as potential side effects from antipsychotic medications that can increase the risk of metabolic syndrome and type 2 diabetes. The study highlights how the chronic stress and lifestyle factors associated with these mental health conditions can significantly impact physical health.

3

Besides natural causes, what 'external causes' significantly contribute to the mortality gap in bipolar disorder and schizophrenia, and why are they important?

Beyond natural causes, external causes such as suicide and accidents play a significant role in the mortality gap observed in individuals with bipolar disorder and schizophrenia. Suicide rates are notably higher in this population, emphasizing the critical need for enhanced mental health support and crisis intervention services. Accidents, potentially linked to impaired judgment or substance abuse, further contribute to this increased risk. Understanding and addressing these external factors is essential for developing comprehensive strategies to reduce preventable deaths and improve overall well-being.

4

What kind of lifestyle factors and medication side effects contribute to the increased risk of cardiovascular disease and diabetes in individuals with bipolar disorder and schizophrenia?

Several lifestyle factors common among individuals with bipolar disorder and schizophrenia contribute to an elevated risk of cardiovascular disease and diabetes. These include higher rates of smoking, poor dietary habits, and sedentary lifestyles, all of which negatively impact cardiovascular health and metabolic function. Additionally, antipsychotic medications, often prescribed for these conditions, can increase the risk of metabolic syndrome and type 2 diabetes, further exacerbating these health issues. Addressing these factors through targeted interventions and lifestyle modifications is crucial for improving health outcomes.

5

What comprehensive strategies can be implemented to bridge the mortality gap for individuals with bipolar disorder and schizophrenia, and what role do different stakeholders play?

Addressing the mortality gap in individuals with bipolar disorder and schizophrenia requires a multi-faceted approach involving healthcare providers, policymakers, and community organizations. Prioritizing mental health involves not just treating symptoms but ensuring opportunities for a long and fulfilling life. Healthcare providers can offer integrated care that addresses both mental and physical health needs, including routine screening for cardiovascular disease, diabetes, and respiratory illnesses. Policymakers can allocate resources to support mental health services, promote early intervention programs, and implement policies that reduce stigma and discrimination. Community organizations can provide support services, promote social inclusion, and advocate for the rights of individuals with mental health conditions.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.